The MonumenTAL-1, MajesTEC-2, OPTIMUM/MUKnine, and GMMG-CONCEPT trials have shown promising results for patients with newly diagnosed or relapsed/refractory multiple myeloma.
Data suggest that most patients who use medical aid in dying (MAID) have cancer, but some oncology providers do not feel well informed about MAID.
Changes to abortion laws in the US could have unintended consequences for cancer patients and others seeking fertility preservation.
Experts outline ways in which health care providers and employers can support cancer patients and caregivers in the workplace.
Of more than 2500 trials analyzed, 21% were randomized.
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
The biosimilars proved as effective as the original biologics in all cancers studied.
Sugemalimab demonstrated efficacy in combination with chemotherapy and as consolidation after chemoradiotherapy.
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
